Low-density lipoprotein apheresis for PLA2R-related membranous glomerulonephritis accompanied by IgG4-related tubulointerstitial nephritis

[1]  A. Tanaka,et al.  Effect of Low‐Density Lipoprotein Apheresis for Nephrotic Idiopathic Membranous Nephropathy as Initial Induction Therapy , 2019, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[2]  J. Stone,et al.  Phospholipase A2 receptor–associated membranous nephropathy in a patient with IgG4-related disease , 2019, Medicine.

[3]  K. Nakajima,et al.  A case of IgG4-related tubulointerstitial nephritis and membranous glomerulonephritis during the clinical course of gastric cancer: Imaging features of IgG4-related kidney disease , 2019, Modern rheumatology.

[4]  M. Kawano,et al.  IgG4-related kidney disease and retroperitoneal fibrosis: An update , 2019, Modern rheumatology.

[5]  C. Conry‐Cantilena,et al.  Treatment‐resistant PLA2R‐negative membranous nephropathy responsive to low‐density lipoprotein apheresis , 2018, Journal of clinical apheresis.

[6]  H. Yokoi,et al.  A Refractory Case of Secondary Membranous Nephropathy Concurrent with IgG4-related Tubulointerstitial Nephritis , 2018, Internal medicine.

[7]  D. Roccatello,et al.  IgG4-related kidney disease: the effects of a Rituximab-based immunosuppressive therapy , 2018, Oncotarget.

[8]  Wei Zhang,et al.  Combined membranous nephropathy and tubulointerstitial nephritis as a rare renal manifestation of IgG4-related disease: a case-based literature review , 2018, CEN Case Reports.

[9]  M. Kawano,et al.  New clues to the nature of immunoglobulin G4-related disease: a retrospective Japanese multicenter study of baseline clinical features of 334 cases , 2017, Arthritis Research & Therapy.

[10]  K. Zheng,et al.  Immunoglobulin G4-related kidney disease: Pathogenesis, diagnosis, and treatment , 2017, Chronic diseases and translational medicine.

[11]  K. Ohashi,et al.  Long-term Low-density Lipoprotein Apheresis in a Patient with Refractory Idiopathic Membranous Glomerulonephritis , 2017, Internal medicine.

[12]  M. Moutschen,et al.  IgG4-related membranous glomerulonephritis and generalized lymphadenopathy without pancreatitis: a case report , 2017, BMC Nephrology.

[13]  K. Node,et al.  Impact of low‐density lipoprotein apheresis for nephrotic syndrome in a patient with immunoglobulin M nephropathy , 2016, Nephrology.

[14]  F. Díaz,et al.  IgG4-related disease and idiopathic membranous nephropathy: 
"The clothes do not make the man"
. , 2016, Clinical nephrology.

[15]  Tsutomu Inoue,et al.  Successful Treatment of C1q Nephropathy by Low‐Density Lipoprotein Apheresis , 2016, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[16]  I. Narita,et al.  Recovery of renal function after glucocorticoid therapy for IgG4-related kidney disease with renal dysfunction , 2015, Clinical and Experimental Nephrology.

[17]  P. Walker,et al.  Membranous nephropathy as a rare renal manifestation of IgG4-related disease , 2015, Indian journal of nephrology.

[18]  N. Yorioka,et al.  Immediate therapeutic efficacy of low-density lipoprotein apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS Study , 2015, Clinical and Experimental Nephrology.

[19]  K. Stylianou,et al.  Acute Interstitial Nephritis and Membranous Nephropathy in the Context of IgG4-Related Disease , 2014, Case Reports in Nephrology and Dialysis.

[20]  M. Hirokawa,et al.  Membranous nephropathy with monoclonal IgG4 deposits and associated IgG4-related lung disease , 2014, Clinical kidney journal.

[21]  Y. Nishio,et al.  IgG4-Related Tubulointerstitial Nephritis Associated with Membranous Nephropathy in Two Patients: Remission after Administering a Combination of Steroid and Mizoribine , 2014, Case reports in nephrology.

[22]  E. Muso.  Beneficial effect of LDL-apheresis in refractory nephrotic syndrome , 2014, Clinical and Experimental Nephrology.

[23]  I. Narita,et al.  Development of IgG4-related disease in a patient diagnosed with idiopathic membranous nephropathy , 2013, Clinical kidney journal.

[24]  E. Imai,et al.  Membranous nephropathy associated with type 1 autoimmune pancreatitis and dominant glomerular IgG4 deposit , 2013, CEN Case Reports.

[25]  E. Messias,et al.  Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies , 2013, Modern Pathology.

[26]  N. Takahashi,et al.  Membranous glomerulonephritis is a manifestation of IgG4-related disease. , 2013, Kidney international.

[27]  J. Stone.  IgG4: a tantalizing link between causes of membranous glomerulonephritis and systemic disease. , 2013, Kidney international.

[28]  T. Sawada,et al.  Membranous nephropathy with repeated flares in IgG4-related disease , 2013, Clinical kidney journal.

[29]  P. Xu,et al.  IgG4-related membranous nephropathy with high blood and low urine IgG4/IgG ratio: a case report and review of the literature , 2013, Clinical Rheumatology.

[30]  A. Krasinskas,et al.  Membranous nephropathy: a rare renal manifestation of IgG4-related systemic disease. , 2012, Clinical Nephrology.

[31]  S. Tsunoda,et al.  Low-density lipoprotein apheresis therapy for steroid- and cyclosporine-resistant idiopathic membranous nephropathy. , 2012, Internal medicine.

[32]  N. Yamanaka,et al.  Proposal for diagnostic criteria for IgG4-related kidney disease , 2011, Clinical and Experimental Nephrology.

[33]  L. Beck,et al.  IgG4-related tubulointerstitial nephritis with membranous nephropathy. , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[34]  G. Remuzzi,et al.  Membranous nephropathy associated with IgG4-related disease. , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[35]  S. Nishi,et al.  Membranous nephropathy associated with IgG4-related systemic disease and without autoimmune pancreatitis. , 2009, Clinical nephrology.

[36]  T. Nakamura,et al.  Low-density lipoprotein apheresis in a patient with arteriosclerosis obliterans and light chain deposition disease. , 2004, Clinical nephrology.

[37]  K. Kiyosawa,et al.  Effect of low-density lipoprotein-apheresis on nephrotic syndrome due to membranous nephropathy in renal allograft: a case report. , 2000, Transplantation proceedings.

[38]  M. Nakayama,et al.  Dextran sulphate cellulose columns for the treatment of nephrotic syndrome due to inactive lupus nephritis. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[39]  Shuzo Kobayashi.  LDL-Apheresis for Diabetic Nephropathy: A Possible New Tool , 1998, Nephron.

[40]  S. Sasayama,et al.  Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis? , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[41]  T. Miyahara,et al.  Possible therapeutic application of low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS). , 1988, Nihon Jinzo Gakkai shi.